HalioDx logo

HalioDx

Diagnostic tests in oncology utilizing the immune contexture of cancers.

1

Funding Rounds

$22.6m

Money raised

Overview

Diagnostic tests in oncology utilizing the immune contexture of cancers.

Funding series

Funding Series Analysis

The company HalioDx has raised a total of $22.6m in funding over 1 rounds.

Key Insights:

  • Haliodx Series B round, January 2018: $22.6m
HalioDx logo
Haliodx Series B round, January 2018 $22.6m